Parkman Healthcare Partners LLC
CIK: 0001777015Latest portfolio: $1.1B · Q4 2025
Holdings
100
Total Value
$1.1B
New Positions
20
Closed Positions
11
Top Holdings
View All 100 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | BSXBOSTON SCIENTIFIC CORP | 500,529 | $47.7M | 4.54% | +66K | |
| 2 | PODDINSULET CORP | 140,860 | $40.0M | 3.81% | +25K | |
| 3 | DC4DEXCOM INC | 587,475 | $39.0M | 3.71% | +416K | |
| 4 | SYKSTRYKER CORPORATION | 105,472 | $37.1M | 3.53% | +41K | |
| 5 | CVSCVS HEALTH CORP | 450,212 | $35.7M | 3.40% | +71K | |
| 6 | MCKMCKESSON CORP | 36,355 | $29.8M | 2.84% | +8K | |
| 7 | KALVKALVISTA PHARMACEUTICALS INC | 1,768,508 | $28.6M | 2.72% | +34K | |
| 8 | MBXMBX BIOSCIENCES INC | 885,639 | $27.9M | 2.66% | +112K | |
| 9 | KNSAKINIKSA PHARMACEUTICALS INTL | 665,208 | $27.4M | 2.61% | -6,384 | |
| 10 | 3M4MASIMO CORP | 200,000 | $26.0M | 2.48% | NEW | |
| 11 | LIVNLIVANOVA PLC | 410,912 | $25.3M | 2.41% | +135K | |
| 12 | TERNTERNS PHARMACEUTICALS INC | 620,877 | $25.1M | 2.39% | -313,883 | |
| 13 | VRDNVIRIDIAN THERAPEUTICS INC | 788,076 | $24.5M | 2.33% | -366,411 | |
| 14 | RCUSARCUS BIOSCIENCES INC | 968,602 | $23.1M | 2.20% | +316K | |
| 15 | UPBUPSTREAM BIO INC | 834,559 | $22.7M | 2.16% | -8,943 | |
| 16 | QGENQIAGEN NV | 494,351 | $22.2M | 2.12% | -5,808 | |
| 17 | AM6AMICUS THERAPEUTICS INC | 1,487,283 | $21.2M | 2.02% | -200,035 | |
| 18 | EYPTEYEPOINT INC | 1,088,033 | $19.9M | 1.89% | NEW | |
| 19 | ALNYALNYLAM PHARMACEUTICALS INC | 47,703 | $19.0M | 1.81% | -39,987 | |
| 20 | NBIXNEUROCRINE BIOSCIENCES INC | 114,712 | $16.3M | 1.55% | -27,110 | |
| 21 | WATWATERS CORP | 41,899 | $15.9M | 1.51% | NEW | |
| 22 | MTDMETTLER TOLEDO INTERNATIONAL | 10,988 | $15.3M | 1.46% | NEW | |
| 23 | MLYSMINERALYS THERAPEUTICS INC | 410,249 | $14.9M | 1.42% | -45,274 | |
| 24 | STOKSTOKE THERAPEUTICS INC | 430,155 | $13.7M | 1.30% | +180K | |
| 25 | AG8AGILENT TECHNOLOGIES INC | 100,000 | $13.6M | 1.30% | NEW |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Unknown0.0% ($3.899026012211781e+25T)
Technology0.0% ($12.1B)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.1B | 100 |
| Q3 2025 | Nov 14, 2025 | $958.7B | 91 |
| Q2 2025 | Aug 14, 2025 | $870.1B | 88 |
| Q1 2025 | May 15, 2025 | $843.1B | 91 |
| Q4 2024 | Feb 14, 2025 | $750.9B | 89 |
| Q3 2024 | Nov 14, 2024 | $783.4B | 93 |
| Q2 2024 | Aug 14, 2024 | $746.6B | 90 |
| Q1 2024 | May 15, 2024 | $815.0B | 99 |
| Q4 2023 | Feb 14, 2024 | $709.9B | 89 |
| Q3 2023 | Nov 14, 2023 | $545.8B | 102 |
| Q2 2023 | Aug 11, 2023 | $576.9B | 95 |
| Q1 2023 | May 12, 2023 | $459.8B | 83 |
| Q4 2022 | Feb 13, 2023 | $375.5B | 81 |
| Q3 2022 | Nov 14, 2022 | $351.7M | 89 |
| Q2 2022 | Aug 12, 2022 | $271.5M | 76 |
| Q1 2022 | May 13, 2022 | $341.7M | 80 |
| Q4 2021 | Feb 11, 2022 | $453.2M | 84 |
| Q3 2021 | Nov 12, 2021 | $395.3M | 74 |
| Q2 2021 | Aug 13, 2021 | $457.4M | 82 |
| Q1 2021 | May 14, 2021 | $430.9M | 83 |
| Q4 2020 | Feb 12, 2021 | $390.3M | 83 |
| Q3 2020 | Nov 13, 2020 | $377.7M | 84 |
| Q2 2020 | Aug 13, 2020 | $355.0M | 79 |
| Q1 2020 | May 15, 2020 | $215.8M | 66 |
| Q4 2019 | Feb 13, 2020 | $346.4M | 69 |
Fund Information
Parkman Healthcare Partners LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.1B across 100 holdings. The largest position is BOSTON SCIENTIFIC CORP (BSX), representing 4.5% of the portfolio. Compared to the previous quarter, the fund opened 20 new positions and closed 11 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.